Upcoming events

TAVI with the SAPIEN family is an established and efficient procedure

Sponsored by Edwards Lifesciences

Chairpersons: I. Al Rashdan, M. Tuzcu

Learning Objectives

  • To learn from the latest evidence in the field of TAVI
  • To understand what the intermediate risk indication means for your patient selection
  • To learn how the TAVI procedure can be further streamlined with new generation delivery systems and valves and how the efficiencies can be leveraged

Presentations available when logged in:

  • Latest clinical evidence data on SAPIEN 3
  • Is durability a concern for lower-risk patient population?
  • Are risk scores the best way to consider TAVI?
  • Considerations to streamline the TAVI procedure and the value of TAVI for the patient